167
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Nutritional management of lipids for overweight and obesity: what can we achieve?

, PhD, & , PhD, RD
Pages 573-584 | Published online: 18 Jan 2017

Bibliography

  • Levi J, Gadola E, Segal LM: F as in fat: howobesity policies are failing in America. Trustfor America's Health, Washington, DC,USA (2007).
  • Presents overweight and obesitytrends and statistics for the USA, anddiscusses current policies and futurestrategies for reducing the incidenceof obesity.
  • Eckel RH: Obesity and heart disease:a statement for healthcare professionals fromthe nutrition committee, American HeartAssociation. Circulation 96, 3248–3250(1997).
  • Rabkin SW, Mathewson FAL, Hsu P-H:Relation of body weight to development ofischemic heart disease in a cohort of youngnorth American men after a 26 year observation period: the Manitoba study.Am. J. Cardiol. 39, 452–458 (1977).
  • Manson JE, Willett WC, Stampfer MJet al.: Body weight and mortality amongwomen. N. Engl. J. Med. 333, 677–685(1995).
  • Bibbins-Domingo K, Coxson P,Pletcher MJ, Lightwood J, Goldman L:Adolescent overweight and future adultcoronary heart disease. N. Engl. J. Med. 357,2371–2379 (2007).
  • Wilson PWF, D'Agostino RB, Parise H,Sullivan L, Meigs JB: Metabolic syndromeas a precursor of cardiovascular disease andType 2 diabetes mellitus. Circulation 112,3066–3072 (2005).
  • Bastard JP, Maachi M, Lagathu C et al.:Recent advances in the relationship betweenobesity, inflammation, and insulinresistance. Eur. Cytokine Netw. 17, 4–12(2006).
  • National Cholesterol Education Panel(NCEP) Expert Panel on DetectionEvaluation, and Treatment of High Bloodcholesterol in Adults (Adult TreatmentPanel III): Third Report of the NationalCholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, andTreatment of High Blood Cholesterol inAdults (Adult Treatment Panel III) FinalReport. Circulation 106, 3143–3421(2002).
  • Bansal S, Buring JE, Rifai N et al.: Fastingcompared with nonfasting triglycerides andrisk of cardiovascular events in women.JAMA 298, 309–316 (2007).
  • Nordestgaard BG, Benn M, Schnohr P,Tybjaerg-Hansen A: Nonfasting triglyceridesand risk of myocardial infarction, ischemicheart disease, and death in men and women.JAMA 298, 299–308 (2007).
  • Castelli WP, Anderson K, Wilson PW,Levy D: Lipids and risk of coronary heartdisease. The Framingham Study. Ann.Epidemiol. 2, 23–28 (1992).
  • Mozaffarian D: Effects of dietary fats versuscarbohydrates on coronary heart disease:a review of the evidence. Curr. Atheroscler.Rep. 7, 435–445 (2005).
  • Yancy WS Jr, Westman EC, French PA,Califf RM: Diets and clinical coronaryevents: the truth is out there. Circulation107, 10–16 (2003).
  • Dattilo AM, Kris-Etherton PM: Effects ofweight reduction on blood lipids andlipoproteins: a meta-analysis. Am. J. Clin.Nutr. 56, 320–328 (1992).
  • Lee M, Aronne LJ: Weight management forType 2 diabetes mellitus: globalcardiovascular risk reduction. Am. J. Cardiol.99, 68–79 (2007).
  • Roussell M, Kris-Etherton P: Effects oflifestyle interventions on high-densitylipoprotein cholesterol levels. J. Clin.Lipidol. 1, 65–73 (2007).
  • Lichtenstein AH, Appel LJ, Brands Met al.: Diet and lifestyle recommendationsrevision 2006: a scientific statement fromthe American Heart Association NutritionCommittee. Circulation 114, 82–96(2006).
  • US Department of Health and HumanServices and US Department of Agriculture:Dietary Guidelines for Americans.Government Printing Office, Washington,DC (2005).
  • The Diabetes Prevention Program ResearchGroup: The Diabetes Prevention Program(DPP): description of lifestyle intervention.Diabetes Care 25, 2165–2171 (2002).
  • Pi-Sunyer X, Blackburn G, Brancati FLet al.: Reduction in weight andcardiovascular disease risk factors inindividuals with Type 2 diabetes: one-yearresults of the Look AHEAD trial. DiabetesCare 30, 1374–1383 (2007).
  • Koertge J, Weidner G, Elliott-Eller Met al.: Improvement in medical risk factorsand quality of life in women and menwith coronary artery disease in theMulticenter Lifestyle DemonstrationProject. Am. J. Cardiol. 91, 1316–1322(2003).
  • Esposito K, Marfella R, Ciotola M et al.:Effect of a Mediterranean-style diet onendothelial dysfunction and markers ofvascular inflammation in the metabolicsyndrome: a randomized trial. JAMA 292,1440–1446 (2004).
  • Long-term study demonstratingthat lifestyle changes, including aMediterranean diet, improve bodyweight and markers of cardiovasculardisease (CVD) and inflammation inpatients with metabolic syndrome (MetS).
  • Dansinger ML, Gleason JA, Griffith JL,Selker HP, Schaefer EJ: Comparison of theAtkins, Ornish, Weight Watchers, and Zonediets for weight loss and heart disease riskreduction: a randomized trial. JAMA 293,43–53 (2005).
  • Gardner CD, Kiazand A, Alhassan S et al.:Comparison of the Atkins, Zone, Ornish,and LEARN Diets for change in weight andrelated risk factors among overweightpremenopausal women: the A to Z weightloss study: a randomized trial. JAMA 297,969–977 (2007).
  • Ebbeling CB, Leidig MM, Feldman HA,Lovesky MM, Ludwig DS: Effects of a lowglycemicload vs low-fat diet in obese youngadults: a randomized trial. JAMA 297,2092–2102 (2007).
  • Pereira MA, Swain J, Goldfine AB,Rifai N, Ludwig DS: Effects of alow-glycemic load diet on resting energyexpenditure and heart disease risk factorsduring weight loss. JAMA 292,2482–2490 (2004).
  • Volek JS, Fernandez ML, Feinman RD,Phinney SD: Dietary carbohydraterestriction induces a unique metabolic statepositively affecting atherogenicdyslipidemia, fatty acid partitioning, andmetabolic syndrome. Prog. Lipid Res. 47,307–318 (2008).
  • Detailed review discussing the effect ofcarbohydrate restriction on insulin controland atherogenic dyslipidemia, withimplications for MetS.
  • Westman EC, Yancy JWS, Olsen MK,Dudley T, Guyton JR: Effect of a lowcarbohydrate,ketogenic diet programcompared to a low-fat diet on fastinglipoprotein subclasses. Int. J. Cardiol. 110,212–216 (2006).
  • Marshall DA, Vernalis MN, Remaley ATet al.: The role of exercise in modulatingthe impact of an ultralow-fat diet onserum lipids and apolipoproteins inpatients with or at risk for coronary arterydisease. Am. Heart J. 151, 484–491(2006).
  • Wing RR, Phelan S: Long-term weight lossmaintenance. Am. J. Clin. Nutr. 82,S222–S225 (2005).
  • Keys A: The relation in man betweencholesterol levels in the diet and inthe blood. Science 112, 79–81(1950).
  • Mensink RP, Zock PL, Kester ADM,Katan MB: Effects of dietary fatty acids andcarbohydrates on the ratio of serum total toHDL cholesterol and on serum lipids andapolipoproteins: a meta-analysis of 60controlled trials. Am. J. Clin. Nutr. 77,1146–1155 (2003).
  • Meta-analysis of 60 studies reporting theeffects of dietary fat and carbohydrate onlipids and lipoproteins.
  • The Expert Panel: Report of the NationalCholesterol Education Program ExpertPanel on detection, evaluation, andtreatment of high blood cholesterol inadults. Arch. Intern. Med. 148, 36–69(1988).
  • The Expert Panel: Summary of the SecondReport of the National CholesterolEducation Program (NCEP) Expert Panelon Detection, Evaluation, and Treatment ofHigh Blood Cholesterol in Adults (AdultTreatment Panel II). JAMA 269, 3015–3023(1993).
  • Schaefer EJ, Lamon-Fava S, Ausman LMet al.: Individual variability in lipoproteincholesterol response to NationalCholesterol Education Program Step 2diets. Am. J. Clin. Nutr. 65, 823–830(1997).
  • Jenkins DJA, Kendall CWC, Faulkner Det al.: A dietary portfolio approach tocholesterol reduction: combined effects ofplant sterols, vegetable proteins, and viscousfibers in hypercholesterolemia. Metabolism51, 1596–1604 (2002).
  • Jenkins DJA, Kendall CWC, Marchie Aet al.: Effects of a dietary portfolio ofcholesterol-lowering foods vs lovastatin onserum lipids and C-reactive protein. JAMA290, 502–510 (2003).
  • Jenkins DJA, Kendall CWC, Marchie A et al.:Direct comparison of a dietary portfolio ofcholesterol-lowering foods with a statin inhypercholesterolemic participants. Am. J. Clin.Nutr. 81, 380–387 (2005).
  • Obarzanek E, Sacks FM, Vollmer WMet al.: Effects on blood lipids of a bloodpressure-lowering diet: the DietaryApproaches to Stop Hypertension (DASH) Trial. Am. J. Clin. Nutr. 74, 80–89 (2001).
  • Howard BV, Van Horn L, Hsia J et al.: Low-fatdietary pattern and risk of cardiovasculardisease: The Women's Health InitiativeRandomized Controlled Dietary ModificationTrial. JAMA 295, 655–666 (2006).
  • Appel LJ, Sacks FM, Carey VJ et al.: Effectsof protein, monounsaturated fat, andcarbohydrate intake on blood pressure andserum lipids: results of the OmniHeartrandomized trial. JAMA 294, 2455–2464(2005).
  • This controlled clinical trial shows thatpartial substitution of carbohydrate withprotein or unsaturated fat results in greaterimprovements in CVD risk factors.
  • Estruch R, Martinez-Gonzalez MA,Corella D et al.: Effects of a Mediterraneanstylediet on cardiovascular risk factors:a randomized trial. Ann. Intern. Med. 145,1–11 (2006).
  • Putnam JJ, Allshouse JA: Food consumption,prices and expenditures, 1970–1997. USDepartment of Agriculture, WashingtonDC, USA (1999).
  • Pawlak DB, Ebbeling CB, Ludwig DS:Should obese patients be counselled tofollow a low-glycaemic index diet? Yes. Obes.Rev. 3, 235–243 (2002).
  • Nordmann AJ, Nordmann A, Briel M et al.:Effects of low-carbohydrate vs low-fat diets onweight loss and cardiovascular risk factors: ameta-analysis of randomized controlled trials.Arch. Intern. Med. 166, 285–293 (2006).
  • Compares the effect of low fat versus lowcarbohydrate dietary interventions onCVD risk factors.
  • Westman EC, Feinman RD,Mavropoulos JC et al.: Low-carbohydratenutrition and metabolism. Am. J. Clin. Nutr.86, 276–284 (2007).
  • Krauss RM, Blanche PJ, Rawlings RS,Fernstrom HS, Williams PT: Separate effectsof reduced carbohydrate intake and weightloss on atherogenic dyslipidemia. Am. J.Clin. Nutr. 83, 1025–1031 (2006).
  • Ridker PM, Hennekens CH, Buring JE,Rifai N: C-reactive protein and othermarkers of inflammation in the predictionof cardiovascular disease in women. N. Engl.J. Med. 342, 836–843 (2000).
  • Ridker PM: High-sensitivity C-reactiveprotein: potential adjunct for global riskassessment in the primary prevention ofcardiovascular disease. Circulation 103,1813–1818 (2001).
  • Ridker PM, Glynn RJ, Hennekens CH:C-reactive protein adds to the predictivevalue of total and HDL cholesterol indetermining risk of first myocardialinfarction. Circulation 97, 2007–2011(1998).
  • Ridker PM, Rifai N, Rose L, Buring JE,Cook NR: Comparison of C-reactiveprotein and low-density lipoproteincholesterol levels in the prediction of firstcardiovascular events. N. Engl. J. Med. 347,1557–1565 (2002).
  • Smith SC Jr, Anderson JL, Cannon RO IIIet al.: CDC/AHA workshop on markers ofinflammation and cardiovascular disease:application to clinical and public healthpractice: report from the clinical practicediscussion group. Circulation 110,E550–E553 (2004).
  • Frohlich M, Imhof A, Berg G et al.:Association between C-reactive protein andfeatures of the metabolic syndrome:a population-based study. Diabetes Care 23,1835–1839 (2000).
  • Tamakoshi K, Yatsuya H, Kondo T et al.:The metabolic syndrome is associated withelevated circulating C-reactive protein inhealthy reference range, a systemiclow-grade inflammatory state. Int. J. Obes.Relat. Metab. Disord. 27, 443–449 (2003).
  • Visser M, Bouter LM, McQuillan GM,Wener MH, Harris TB: Elevated C-reactiveprotein levels in overweight and obeseadults. JAMA 282, 2131–2135 (1999).
  • O'Brien KD, Brehm BJ, Seeley RJ et al.: Dietinducedweight loss is associated with decreasesin plasma serum amyloid A and C-reactiveprotein independent of dietary macronutrientcomposition in obese subjects. J. Clin.Endocrinol. Metab. 90, 2244–2249 (2005).
  • Selvin E, Paynter NP, Erlinger TP: Theeffect of weight loss on C-reactive protein:a systematic review. Arch. Intern. Med. 167,31–39 (2007).
  • Seshadri P, Iqbal N, Stern L et al.:A randomized study comparing the effectsof a low-carbohydrate diet and aconventional diet on lipoproteinsubfractions and C-reactive protein levels inpatients with severe obesity. Am. J. Med.117, 398–405 (2004).
  • King DE, Egan BM, Geesey ME: Relationof dietary fat and fiber to elevation ofC-reactive protein. Am. J. Cardiol. 92,1335–1339 (2003).
  • Ma Y, Griffith JA, Chasan-Taber L et al.:Association between dietary fiber and serumC-reactive protein. Am. J. Clin. Nutr. 83,760–766 (2006).
  • Ajani UA, Ford ES, Mokdad AH: Dietaryfiber and C-reactive protein: findings fromNational Health and Nutrition ExaminationSurvey Data. J. Nutr. 134, 1181–1185(2004).
  • Zhao G, Etherton TD, Martin KR et al.:Dietary -linolenic acid reducesinflammatory and lipid cardiovascular riskfactors in hypercholesterolemic men andwomen. J. Nutr. 134, 2991–2997 (2004).
  • Basu A, Devaraj S, Jialal I: Dietary factorsthat promote or retard inflammation.Arterioscler. Thromb. Vasc. Biol. 26,995–1001 (2006).
  • Jenkins DJ, Kendall CW, Marchie A et al.:Direct comparison of dietary portfolio vsstatin on C-reactive protein. Eur. J. Clin.Nutr. 59, 851–860 (2005).
  • King DE, Egan BM, Woolson RF et al.:Effect of a high-fiber diet vs a fibersupplementeddiet on C-reactive proteinlevel. Arch. Intern. Med. 167, 502–506(2007).
  • Jansen S, Lopez-Miranda J, Salas J et al.:Plasma lipid response to hypolipidemic dietsin young healthy non-obese men varies withbody mass index. J. Nutr. 128, 1144–1149(1998).
  • Lefevre M, Champagne CM, Tulley RT, RoodJC, Most MM: Individual variability incardiovascular disease risk factor responses tolow-fat and low-saturated-fat diets in men:body mass index, adiposity, and insulinresistance predict changes in LDL cholesterol.Am. J. Clin. Nutr. 82, 957–963 (2005).
  • Erlinger TP, Miller ER III, Charleston J,Appel LJ: Inflammation modifies the effectsof a reduced-fat low-cholesterol diet onlipids: results from the DASH-sodium trial.Circulation 108, 150–154 (2003).
  • Dietary intervention study demonstratingthat elevated levels of CRP can lessen thebeneficial effects of a cholesterol loweringdiet in overweight individuals.
  • Hilpert KF, Kris-Etherton PM, West SG:Lipid response to a low-fat diet with orwithout soy is modified by C-reactiveprotein status in moderatelyhypercholesterolemic adults. J. Nutr. 135,1075–1079 (2005).
  • Demonstrates that the cholesterol loweringeffects of a low fat diet are blunted byincreased levels of inflammation.
  • Berglund L, Lefevre M, Ginsberg HNet al.: Comparison of monounsaturated fat with carbohydrates as a replacementfor saturated fat in subjects with ahigh metabolic risk profile: studiesin the fasting and postprandial states.Am. J. Clin. Nutr. 86, 1611–1620(2007).
  • Jenkins DJA, Kendall CWC,Faulkner DA et al.: Assessment of thelonger-term effects of a dietary portfolioof cholesterol-lowering foods inhypercholesterolemia. Am. J. Clin. Nutr.83, 582–591 (2006).
  • Varady KA, Jones PJH: Combinationdiet and exercise interventionsfor the treatment of dyslipidemia:an effective preliminary strategy to lowercholesterol levels? J. Nutr. 135,1829–1835 (2005).
  • Esmaillzadeh A, Kimiagar M, Mehrabi Yet al.: Fruit and vegetable intakes,C-reactive protein, and the metabolicsyndrome. Am. J. Clin. Nutr. 84,1489–1497 (2006).
  • Gao X, Bermudez OI, Tucker KL: PlasmaC-reactive protein and homocysteineconcentrations are related to frequent fruitand vegetable intake in Hispanic andnon-Hispanic white elders. J. Nutr. 134,913–918 (2004).
  • Jiang R, Jacobs DR Jr, Mayer-Davis E et al.:Nut and seed consumption andinflammatory markers in the multi-ethnicstudy of atherosclerosis. Am. J. Epidemiol.163, 222–231 (2006).
  • Liu S, Manson JE, Buring JE et al.:Relation between a diet with a highglycemic load and plasma concentrationsof high-sensitivity C-reactive protein inmiddle-aged women. Am. J. Clin. Nutr.75, 492–498 (2002).
  • Zampelas A, Panagiotakos DB, Pitsavos C et al.: Fish consumption among healthyadults is associated with decreased levels ofinflammatory markers related tocardiovascular disease: the ATTICA Study.J. Am. Coll. Cardiol. 46, 120–124 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.